Browsing by Author "Dehade A."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Late-Onset Inflammatory Bowel Disease and Flares in Adenoviral and Inactivated Coronavirus Vaccine Recipients
    (Lippincott Williams and Wilkins, 2024) Kaur U.; Krishna D.V.V.; Reddy J.; Reddy N.T.S.; Dehade A.; Chakrabarti S.S.; Yadav D.P.
    [No abstract available]
  • Thumbnail Image
    Item
    Patterns and outcomes of late onset thyroid disturbances after COVID-19 vaccination: A report of 75 cases
    (John Wiley and Sons Inc, 2024) Kaur U.; Reddy N.T.S.; Reddy J.; Krishna D.V.V.; Dehade A.; Agrawal N.K.
    Isolated cases of subacute thyroiditis exist in the early period of COVID-19 vaccination, largely after mRNA vaccines. Here we report late onset thyroid disturbances and persistent health issues in patients of thyroid disorders after COVID-19 vaccination. Seventy-five patients with post COVID-19 vaccination thyroid disturbances were identified. Among these, 41 had flare of underlying thyroid illness, majority occurring at a median time lag of 28.4 weeks since 2nd dose. Thirty-one cases of new onset hypothyroidism and three of new onset hyperthyroidism were reported, with a median time lag respectively of 17.2 and 22.6 weeks since 2nd dose. Most cases occurred after ChAdOx1-nCoV-19, which was the commonest vaccine employed in mass roll out in India. Significant improvement was observed in majority, after a median follow up of 22�26 weeks. New onset health issues persisting for ?4 weeks were reported in 37.3% and were common in individuals with history of COVID-19 before vaccine. New onset metabolic, musculoskeletal, and reproductive disorders were the common health complaints. Active monitoring is warranted for late onset adverse events after COVID-19 vaccines of all types. Larger studies with involvement of unvaccinated individuals are required to understand the incidence and causality of late onset thyroid disturbances after COVID-19 vaccines. � 2023 John Wiley & Sons Ltd.